Trial Profile
Effect of Sativex on neuropathic pain and spasticity following spinal cord injury [Effekten af Sativex på neuropatiske smerter og spasticitet hos rygmarvsskadede]
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2014
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Muscle spasticity; Neuropathic pain
- Focus Therapeutic Use
- 26 Jul 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database
- 05 Jun 2013 New trial record